A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion
Lago-Hernandez, C. A., Feldman, H., O'Donnell, E., Mahal, B. A., Perez, V., Howard, S., Rosenthal, M., Cheng, S. C., Nguyen, P. L., Beard, C., D'Amico, A. V., Sweeney, C. J.Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv180
Date:
April, 2015
File:
PDF, 143 KB
english, 2015